|Articles|September 1, 2003

Follow the Rules

San Francisco - The known teratogenicity of isotretinoin, as well as a possible link to psychiatric illness, means that physicians prescribing the drug must carefully follow risk-management guidelines. These guidelines are mandated by the FDA.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME